Drug Profile


Alternative Names: Etione

Latest Information Update: 21 Jan 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Progenics Pharmaceuticals
  • Class Antianaemics; Antihyperglycaemics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Aplastic anaemia; Obesity; Type 2 diabetes mellitus

Most Recent Events

  • 21 Jan 2002 Discontinued-II for Aplastic anaemia (Unknown route)
  • 21 Jan 2002 Discontinued-II for Obesity (Unknown route)
  • 21 Jan 2002 Discontinued-II for Type-2 diabetes mellitus (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top